After a tumultuous three years marked by halting progress and high rates of employee turnover, Haven — the ambitious health care venture launched by Amazon, JPMorgan Chase, and Berkshire Hathaway — is dissolving.
Haven will cease operations at the end of February, Haven spokesperson Brooke Thurston confirmed to STAT.
“The Haven team made good progress exploring a wide range of healthcare solutions, as well as piloting new ways to make primary care easier to access, insurance benefits simpler to understand and easier to use, and prescription drugs more affordable,” she said. Thurston said the three companies will “continue to collaborate informally” on programs for their individual employee populations.
The news, first reported by CNBC, is sure to send observers in the health tech industry reeling: While Haven had not made any visible signs of progress since its 2018 debut, many outside experts believed its far-reaching endeavors could be realized on a long-term timeline of several years or even a decade.